Co-Diagnostics, Inc. (CODX)

Co-Diagnostics Announces First Full Vector Smart® Laboratory Installation for Native American Tribe

Co-Diagnostics Highlights Vector Smart® Momentum Following New Federal Initiative on Vector-Borne Disease

Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development

Head to Head Review: Halozyme Therapeutics (NASDAQ:HALO) & Co-Diagnostics (NASDAQ:CODX)

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

Co-Diagnostics, Inc. (CODX) Shareholder/Analyst Call Transcript

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

Co-Diagnostics to Hold Press Conference

Co-Diagnostics Completes New Vector Smart® Laboratory Installations Amid Rising Dengue Activity in Florida

Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India

Co-Diagnostics Expands Vector Smart® Customer Reach with First International Installation in USAF Base

Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event

Co-Diagnostics, Inc. (CODX) Q2 2026 Earnings Call Transcript

Co-Diagnostics Reports Second Quarter 2026 Financial Results

Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test

Co-Diagnostics Announces Second Quarter 2026 Earnings Release Date and Webcast

Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies

Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform